Beta Bionics (BBNX) is scheduled to report Q2 earnings on July 28, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of $31.51M.
In the most recent quarter (Q1), Beta Bionics reported EPS of $-0.49, missing estimates of $-0.48 by 0.02%. Revenue came in at $27.63M, exceeding the estimate of $27.28M by 0.01%.
Over the last 4 quarters, Beta Bionics has averaged an EPS surprise of 0.17% and a revenue surprise of 0.09%.
Analyze the earnings history of Beta Bionics using advanced sorting and filters.
The chart below shows Beta Bionics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Beta Bionics's reported revenue compared to analyst estimates over recent quarters.
Beta Bionics (BBNX) is scheduled to report earnings on July 28, 2026. The last reported earnings were for reported on April 21, 2026 for Q1.
The Actual EPS was $-0.49, which missed the estimate of $-0.48.
The Actual Revenue was $27.63M, which beat the estimate of $27.28M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-21 | $-0.49 | $-0.48 | -2.08 % |
| Q4 | 2026-02-17 | $-0.30 | $-0.39 | 23.1 % |
| Q3 | 2025-10-28 | $-0.33 | $-0.43 | 23.3 % |
| Q2 | 2025-07-29 | $-0.39 | $-0.48 | 18.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-21 | $27.63M | $27.28M | 1.27 % |
| Q4 | 2026-02-17 | $32.12M | $31.48M | 2.04 % |
| Q3 | 2025-10-28 | $27.25M | $23.96M | 13.8 % |
| Q2 | 2025-07-29 | $23.24M | $19.70M | 17.9 % |